Pawel Przewiezlikowski, Ryvu Therapeutics CEO
Updated: EU's lending arm grants Polish biotech $22M+ in debt financing to advance pipeline
Many US biotechs have been tightening their pocketbooks in an effort to keep themselves running. But over in Poland, one company is nabbing a debt …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
